Morgan Stanley (NYSE:MS) analyst Joseph Moore revised the price target for Teradyne stock (NASDAQ:TER), dropping it to $112 from the previous $117, while maintaining an Underweight rating on the ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.

Fintel reports that on January 30, 2025, JP Morgan downgraded their outlook for CARGO Therapeutics (NasdaqGS:CRGX) from Overweight to Underweight. Analyst Price Forecast Suggests 146.36% Upside As of ...

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to ...

How JPMorgan Chase performs in 2025 will largely depend on how economic conditions evolve. A backdrop of a firm labor market ...

Vishal Mega Mart's growth strategy looks more defendable than peers' given its scale, according to Morgan Stanley. The risks ...

JPMorgan Chase & Co. filed an 8-K report with the Securities and Exchange Commission, informing shareholders about the ...

JPMorgan raised the firm’s price target on T-Mobile (TMUS) to $265 from $250 and keeps an Overweight rating on the shares. The company reported ...

JPMorgan Chase's Q4 earnings exceeded expectations, with a stable net interest yield. Read why JPM's Series DD and GG ...

JP Morgan analyst Matthew Boss reiterated an Overweight rating on the shares of Viking Holdings Ltd (NYSE:VIK) and raised the ...